PROFOUND MED CORP's ticker is PROF and the CUSIP is 74319B502. A total of 56 filers reported holding PROFOUND MED CORP in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,138,093 | -22.7% | 1,582,166 | -1.4% | 4.04% | -6.9% |
Q2 2023 | $20,882,871 | +30.6% | 1,605,140 | -6.7% | 4.34% | +29.3% |
Q1 2023 | $15,984,039 | -17.5% | 1,720,564 | -3.2% | 3.36% | -21.4% |
Q4 2022 | $19,364,652 | +171.6% | 1,778,205 | +0.6% | 4.28% | +172.6% |
Q3 2022 | $7,131,000 | -26.3% | 1,766,855 | +33.1% | 1.57% | -22.7% |
Q2 2022 | $9,678,000 | -18.8% | 1,327,532 | +0.2% | 2.03% | +4.4% |
Q1 2022 | $11,919,000 | -1.5% | 1,324,335 | +22.9% | 1.94% | +7.2% |
Q4 2021 | $12,099,000 | -14.5% | 1,077,357 | +11.5% | 1.81% | -13.7% |
Q3 2021 | $14,150,000 | +8.0% | 966,536 | +20.7% | 2.10% | +13.0% |
Q2 2021 | $13,102,000 | -16.4% | 800,845 | +3.0% | 1.86% | -22.0% |
Q1 2021 | $15,667,000 | -7.2% | 777,890 | -5.3% | 2.39% | -11.2% |
Q4 2020 | $16,883,000 | +22.8% | 821,196 | +5.3% | 2.69% | -8.3% |
Q3 2020 | $13,751,000 | +10.9% | 779,533 | +6.5% | 2.93% | -2.3% |
Q2 2020 | $12,395,000 | +65.7% | 731,715 | -4.7% | 3.00% | +18.1% |
Q1 2020 | $7,480,000 | -2.0% | 767,926 | +10.2% | 2.54% | +52.2% |
Q4 2019 | $7,630,000 | – | 696,810 | – | 1.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 196,924 | $3,474,000 | 8.11% |
Gagnon Advisors, LLC | 277,252 | $4,891,000 | 3.00% |
GAGNON SECURITIES LLC | 779,533 | $13,751,000 | 2.93% |
Taylor Wealth Management Partners | 166,364 | $2,935,000 | 1.34% |
AWM Investment Company, Inc. | 348,939 | $6,155,000 | 1.01% |
PCJ Investment Counsel Ltd. | 121,560 | $2,137,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 780,567 | $13,769,000 | 0.71% |
Parkman Healthcare Partners LLC | 70,000 | $1,235,000 | 0.33% |
Park West Asset Management LLC | 450,000 | $7,938,000 | 0.31% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 695,000 | $12,260,000 | 0.30% |